Cancer News
OncoLink Cancer News - HealthDay


October 2012 Briefing - Hematology & Oncology

Thursday, November 1, 2012 (Last Updated: 11/02/2012)

Here are what the editors at HealthDay consider to be the most important developments in Hematology & Oncology for October 2012. This roundup includes the latest research news from journal articles, as well as the FDA approvals and regulatory changes that are the most likely to affect clinical practice.

Quality of Life for Cancer Survivors Depends on Type

TUESDAY, Oct. 30 (HealthDay News) -- Survivors of cancers are more likely to report poor physical and mental health-related quality of life (HRQOL), compared with adults without cancer, with considerable variation noted for different types of cancers, according to a study published online Oct. 30 in Cancer Epidemiology, Biomarkers & Prevention.

Abstract
Full Text (subscription or payment may be required)

Adverse Prognostic Factor ID'd in Operable Breast Cancer

TUESDAY, Oct. 30 (HealthDay News) -- For women with operable breast cancer, moderate immunohistochemical expression of human epidermal growth factor receptor (HER)-2 (2+) without amplification of HER-2 (HER-2 2+/HER-2) is an adverse prognostic factor, according to a study published online Sept. 4 in The Oncologist.

Abstract
Full Text (subscription or payment may be required)

U.S. Medicare Spending on Elderly Has Outpaced Canada's

TUESDAY, Oct. 30 (HealthDay News) -- U.S. Medicare spending on the elderly has grown nearly three times faster than its Canadian counterpart, according to a study published online Oct. 29 in the Archives of Internal Medicine.

Full Text (subscription or payment may be required)

Fertility-Sparing Tx Feasible in Early Endometrial Cancer

TUESDAY, Oct. 30 (HealthDay News) -- For women with early-stage endometrial cancer (EC) and atypical complex hyperplasia (ACH), fertility-sparing treatment seems feasible, according to research published in the October issue of the American Journal of Obstetrics & Gynecology.

Abstract
Full Text (subscription or payment may be required)

Oncologists Generally Refer to Specialized Palliative Care Late

TUESDAY, Oct. 30 (HealthDay News) -- Definitional issues and non-acceptance of patients receiving chemotherapy are the barriers to earlier referral to specialized palliative care (SPC) by oncologists, according to a study published online Oct. 29 in the Journal of Clinical Oncology.

Abstract
Full Text (subscription or payment may be required)

Acupuncture Reduces Breast Cancer-Related Fatigue

MONDAY, Oct. 29 (HealthDay News) -- Acupuncture significantly reduces fatigue and improves quality of life in breast cancer patients with cancer-related fatigue, according to a study published online Oct. 29 in the Journal of Clinical Oncology.

Abstract
Full Text (subscription or payment may be required)
Editorial

Potential Biomarker, Drug Target ID'd for Adult Leukemia

MONDAY, Oct. 29 (HealthDay News) -- Tumors from adults with B-cell precursor acute lymphoblastic leukemia (B-ALL) have epigenetic changes, leading to the identification of a potential biomarker and a possible drug target, according to research published online Oct. 29 in Cancer Discovery.

Abstract
Full Text (subscription or payment may be required)

More Intensive Chemo Ups Survival in Ewing Sarcoma

MONDAY, Oct. 29 (HealthDay News) -- More intensive chemotherapy (every two weeks versus every three weeks) improves event-free survival for patients with localized Ewing sarcoma, according to a study published online Oct. 22 in the Journal of Clinical Oncology.

Abstract
Full Text (subscription or payment may be required)

Quitting Before 40 Avoids Most Excess Smoking-Linked Mortality

MONDAY, Oct. 29 (HealthDay News) -- For U.K. women, the hazards of smoking and benefits of quitting are considerable, with women who quit before age 30 avoiding more than 97 percent of excess smoking-related mortality, according to a study published online Oct. 27 in The Lancet.

Abstract
Full Text (subscription or payment may be required)
Editorial (subscription or payment may be required)

Considerable Regional Variation for Brachytherapy

FRIDAY, Oct. 26 (HealthDay News) -- A considerable proportion of Medicare beneficiaries are treated with brachytherapy for breast cancer, with substantial regional variation, according to a study published online Oct. 22 in the Journal of Clinical Oncology.

Abstract
Full Text (subscription or payment may be required)
Editorial

Synribo Approved to Treat Chronic Myelogenous Leukemia

FRIDAY, Oct. 26 (HealthDay News) -- Synribo (omacetaxine mepesuccinate) has been approved by the U.S. Food and Drug Administration to treat chronic myelogenous leukemia (CML).

CML

Negative Pigment Network Able to Distinguish Melanoma

THURSDAY, Oct. 25 (HealthDay News) -- Negative pigment network (NPN) can be used to distinguish melanoma from Spitz nevus and other benign lesions, according to a study published online Oct. 11 in the Journal of the American Academy of Dermatology.

Abstract
Full Text (subscription or payment may be required)

Meta-Analysis: Antivirals Reduce Risk of Liver Cancer in Hep C

THURSDAY, Oct. 25 (HealthDay News) -- Antiviral treatment does significantly reduce the risk of developing liver cancer for patients with chronic hepatitis C infection, particularly in virological responders, according to a meta-analysis published online Oct. 22 in BMJ Open.

Abstract
Full Text

Terminal Cancer Patients May Have Erroneous Chemo Beliefs

WEDNESDAY, Oct. 24 (HealthDay News) -- Patients with stage IV metastatic cancer frequently do not understand that chemotherapy is unlikely to be curative, according to a study published in the Oct. 25 issue of the New England Journal of Medicine.

Full Text (subscription or payment may be required)
Editorial (subscription or payment may be required)

Aspirin Improves Survival for CRC With PIK3CA Mutation

WEDNESDAY, Oct. 24 (HealthDay News) -- Among patients with colorectal cancer (CRC), regular use of aspirin after diagnosis is associated with longer survival for those with the mutated phosphatidylinositol-4,5-bisphosphonate 3-kinase, catalytic subunit alpha polypeptide gene (PIK3CA), according to a study published in the Oct. 25 issue of the New England Journal of Medicine.

Full Text (subscription or payment may be required)
Editorial (subscription or payment may be required)

Better Prognosis for Early Blast Clearance in Leukemia

WEDNESDAY, Oct. 24 (HealthDay News) -- Patients with acute myeloid leukemia whose peripheral blood blasts clear in six days or less after chemotherapy have significantly better survival than patients whose peripheral blasts clear later, according to a study published in the Nov. 1 issue of Cancer.

Abstract
Full Text (subscription or payment may be required)

Decrease in CRC Resections Tied to Medicare-Covered Screening

WEDNESDAY, Oct. 24 (HealthDay News) -- The rates of resection for distal and proximal colorectal cancer (CRC) decreased from 1993 to 2009, with rates of proximal resection decreasing significantly from 2002, after implementation of Medicare payment for screening colonoscopy, according to a study published in the November issue of Gastroenterology.

Abstract
Full Text (subscription or payment may be required)

New Scan Feasible for 3D Diagnosis of Breast Cancer

TUESDAY, Oct. 23 (HealthDay News) -- A high-resolution, low-dose phase contrast X-ray tomographic method of three-dimensional (3D) diagnosis, using an image reconstruction method known as equally sloped tomography, can be used to identify malignant breast cancer at clinically compatible doses of radiation, according to research published online Oct. 22 in the Proceedings of the National Academy of Sciences.

Abstract
Full Text (subscription or payment may be required)

Signaling in Prostate Tumors Indicates Responsiveness

TUESDAY, Oct. 23 (HealthDay News) -- A test of the androgen responsiveness of circulating tumor cells in men with metastatic prostate cancer before and after androgen-deprivation therapy may help determine the best subsequent treatment, according to a study published online Oct. 23 in Cancer Discovery.

Abstract
Full Text (subscription or payment may be required)
Editorial (subscription or payment may be required)

Genuine Very Large Effects in Trials Rare in Medicine

TUESDAY, Oct. 23 (HealthDay News) -- Large treatment effects are most likely to be found in small studies, with the effect diminishing with additional trials, according to research published in the Oct. 24 issue of the Journal of the American Medical Association.

Abstract
Full Text (subscription or payment may be required)
Editorial (subscription or payment may be required)

TNF Inhibitor Use Doesn't Up Short-Term Cancer Incidence

MONDAY, Oct. 22 (HealthDay News) -- Treatment of chronic immune-mediated diseases with tumor necrosis factor (TNF) inhibitors does not result in any short-term increase in cancer incidence, compared with other commonly used therapies for these conditions, according to a study published online Oct. 10 in Arthritis & Rheumatism.

Abstract
Full Text (subscription or payment may be required)

Metabolic Factors Impact Risk of Death From Prostate Cancer

MONDAY, Oct. 22 (HealthDay News) -- Metabolic factors are not associated with the risk of prostate cancer, but high levels are associated with increased risk of death from prostate cancer, according to research published online Oct. 22 in Cancer.

Abstract
Full Text (subscription or payment may be required)

Social Outcomes Good for Most Pediatric Brain Tumor Survivors

FRIDAY, Oct. 19 (HealthDay News) -- While the majority of survivors of pediatric embryonal tumors display positive social outcomes several years after diagnosis and treatment, specific risk factors may affect social adjustment and behavior over the long term, according to research published online Oct. 15 in the Journal of Clinical Oncology.

Abstract
Full Text (subscription or payment may be required)

Intracranial Tumors Can Be Resected Safely in Elderly

FRIDAY, Oct. 19 (HealthDay News) -- Elderly patients do not have poorer short-term outcomes after surgical resection of primary or metastatic intracranial tumors, after accounting for other risk factors, according to research published online Oct. 12 in Cancer.

Abstract
Full Text (subscription or payment may be required)

Common Liver Tests Can Predict Liver Cancer Risk

FRIDAY, Oct. 19 (HealthDay News) -- Common liver function tests, including measurement of alanine transaminase (ALT) and aspartate transaminase (AST) levels, can be used to reliably predict hepatocellular carcinoma (HCC) risk in the general population with average or unknown risk, according to research published in the Oct. 17 issue of the Journal of the National Cancer Institute.

Abstract
Full Text (subscription or payment may be required)

Post-Op Radiation Has Lasting Benefit in Prostate Cancer

FRIDAY, Oct. 19 (HealthDay News) -- For men with high-risk prostate cancer, postoperative radiation after radical prostatectomy is associated with improved biochemical progression-free survival over a median of 10.6 years of follow-up, compared with a wait-and-see policy, according to a study published online Oct. 19 in The Lancet.

Abstract
Full Text (subscription or payment may be required)
Editorial (subscription or payment may be required)

Return to Work Difficult for Doctors on Sick Leave

THURSDAY, Oct. 18 (HealthDay News) -- Returning to work after a prolonged sick leave for physical or mental health problems, or drug or alcohol problems, is difficult for doctors, who describe self-stigmatization and fear a negative response on their return to work, according to a study published online Oct. 15 in BMJ Open.

Abstract
Full Text (subscription or payment may be required)

Peripheral Stem Cells, Bone Marrow Yield Similar Survival

WEDNESDAY, Oct. 17 (HealthDay News) -- Among patients with hematological cancer, there are no significant differences in survival for recipients of peripheral-blood stem-cells or bone marrow transplantation from unrelated donors, according to a study published in the Oct. 18 issue of the New England Journal of Medicine.

Full Text (subscription or payment may be required)
Editorial (subscription or payment may be required)

Surgery Linked to Cardiac Death in Cancer Patients

WEDNESDAY, Oct. 17 (HealthDay News) -- Cancer patients who undergo surgery are more than twice as likely to die from a cardiovascular cause within a month of surgery, according to a research letter published in the Oct. 18 issue of the New England Journal of Medicine.

Full Text (subscription or payment may be required)

Universal Screening Modestly Ups Lynch Syndrome Diagnosis

WEDNESDAY, Oct. 17 (HealthDay News) -- In patients with colorectal cancer, universal testing for mutations in genes associated with Lynch syndrome, the most common form of hereditary colorectal cancer, has modestly better diagnostic sensitivity than other strategies, according to a study published in the Oct. 17 issue of the Journal of the American Medical Association.

Abstract
Full Text (subscription or payment may be required)
Editorial (subscription or payment may be required)

About 170 Million Healthy Life-Years Lost to Cancer Globally

TUESDAY, Oct. 16 (HealthDay News) -- The age-adjusted disability-adjusted life-years (DALYs) lost from cancer are considerable, with 169.3 million years of healthy life lost globally in 2008, according to a study published online Oct. 16 in The Lancet.

Abstract
Full Text (subscription or payment may be required)
Editorial (subscription or payment may be required)

Lexatumumab Tolerated for Pediatric Solid Tumors

TUESDAY, Oct. 16 (HealthDay News) -- Lexatumumab, an agonistic, full human monoclonal antibody against tumor necrosis factor-related apoptosis-inducing ligand receptor 2, is well tolerated and may lessen certain clinical symptoms in some pediatric patients with solid tumors, according to a study published online Oct. 15 in the Journal of Clinical Oncology.

Abstract
Full Text (subscription or payment may be required)

Study Suggests How Obesity Promotes Tumor Growth

MONDAY, Oct. 15 (HealthDay News) -- Fat cells can be recruited to tumors where they contribute to the growth of tumor blood vessels, according to a study in the Oct. 15 issue of Cancer Research.

Abstract
Full Text

B-Vitamin Supplement Doesn't Lower Colorectal Cancer Risk

MONDAY, Oct. 15 (HealthDay News) -- A combination of folic acid and vitamins B6 and B12 supplementation does not reduce the risk of colorectal adenoma among high-risk women, according to a study published online Oct. 12 in the Journal of the National Cancer Institute.

Abstract
Full Text (subscription or payment may be required)
Editorial (subscription or payment may be required)

Prognosis After Cystectomy Not Affected by Smoking

MONDAY, Oct. 15 (HealthDay News) -- Despite the link between cigarette smoking and the development of bladder cancer, the prognosis of people with bladder cancer after undergoing a cystectomy is not affected by cigarette smoking, according to research published online Oct. 8 in Urology.

Abstract
Full Text (subscription or payment may be required)

Abraxane Approved to Treat Advanced Lung Cancer

FRIDAY, Oct. 12 (HealthDay News) -- Abraxane (paclitaxel protein-bound) has been approved by the U.S. Food and Drug Administration -- in combination with the drug carboplatin -- to treat advanced or spreading non-small cell lung cancer among people who aren't candidates for surgery or radiation therapy, the agency said Friday.

National Cancer Institute

Gene Signature Validated for Oral Cancer Metastases

FRIDAY, Oct. 12 (HealthDay News) -- A multigene signature effectively predicts the presence of lymph node metastases in squamous cell carcinoma of the oral cavity (OSCC) and oropharynx (OPSCC), according to a study published online Oct. 8 in the Journal of Clinical Oncology.

Abstract
Full Text (subscription or payment may be required)
Editorial

Patient Navigation Speeds Breast Cancer Diagnosis

FRIDAY, Oct. 12 (HealthDay News) -- Patient navigation -- a service that helps patients navigate the health care system, including setting up appointments, dealing with health insurance, and coping with fears about cancer -- leads to quicker breast cancer diagnosis, especially for women requiring biopsy, according to a study published in the October issue of Cancer Epidemiology, Biomarkers & Prevention.

Abstract
Full Text (subscription or payment may be required)

Study Confirms Link Between Analgesic Use, Ovarian Cancer

THURSDAY, Oct. 11 (HealthDay News) -- Use of any analgesic or aspirin correlates with a reduced risk of ovarian cancer, with the reduction significant only for use of any analgesic and serous ovarian cancer, according to a case-control study published in the September issue of ACTA Obstetricia et Gynecologica Scandinavica.

Abstract
Full Text (subscription or payment may be required)

Interventions Helpful for Breast Cancer-Induced Menopause

THURSDAY, Oct. 11 (HealthDay News) -- Cognitive behavioral therapy (CBT) and physical exercise improve endocrine and urinary symptoms as well as physical functioning in patients with breast cancer treatment-induced menopause, according to research published online Oct. 8 in the Journal of Clinical Oncology.

Abstract
Full Text (subscription or payment may be required)
Editorial

HIV Status Doesn't Influence Hodgkin's Lymphoma Outcome

THURSDAY, Oct. 11 (HealthDay News) -- Despite more extensive disease and more adverse prognostic factors, HIV-positive patients with Hodgkin's lymphoma (HL) do not have worse outcomes when treated with doxorubicin, bleomycin, vinblastine, and dacarbazine (ABVD), according to research published online Oct. 8 in the Journal of Clinical Oncology.

Abstract
Full Text (subscription or payment may be required)
Editorial

New Cervical Cancer Vaccine Targets HPV-Infected Women

WEDNESDAY, Oct. 10 (HealthDay News) -- A new candidate vaccine designed to prevent cervical dysplasia and cancer in women already infected with human papillomavirus (HPV) serotypes 16 and 18 is well tolerated and induces a robust immune response, according to a phase 1 study published in the Oct. 10 issue of Science Translational Medicine.

Abstract
Full Text (subscription or payment may be required)

Proneurotensin Linked to Increased Disease, Death Risk

TUESDAY, Oct. 9 (HealthDay News) -- Plasma levels of proneurotensin are associated with the future development of diabetes, cardiovascular disease, and cardiovascular and total mortality, as well as breast cancer in women, according to a study published in the Oct. 10 issue of the Journal of the American Medical Association.

Abstract
Full Text (subscription or payment may be required)

Physical Activity Moderately Ups Bleed Risk in Hemophilia

TUESDAY, Oct. 9 (HealthDay News) -- There is a moderate but significant transient increased risk in bleeding following vigorous physical activity in children and adolescent boys with hemophilia, according to a study published in the Oct. 10 issue of the Journal of the American Medical Association.

Abstract
Full Text (subscription or payment may be required)
Editorial (subscription or payment may be required)

Gene Signatures Predict Outcome in Prostate Cancer

TUESDAY, Oct. 9 (HealthDay News) -- Gene expression signatures can identify men with low- or high-risk advanced prostate cancer, according to two studies published online Oct. 9 in The Lancet Oncology.

Abstract - Ross
Full Text (subscription or payment may be required)
Abstract - Olmos
Full Text (subscription or payment may be required)
Editorial (subscription or payment may be required)

Large Review Confirms Melanoma Risk Up in Immunosuppressed

TUESDAY, Oct. 9 (HealthDay News) -- Immunosuppressed patients, particularly solid-organ transplant recipients and lymphoma patients, have about a two-fold or higher risk of developing melanoma, according to research published in the October issue of the Mayo Clinic Proceedings.

Abstract
Full Text

Unsuspected PE Seldom Linked to Death in Cancer Patients

TUESDAY, Oct. 9 (HealthDay News) -- Unsuspected pulmonary embolism (UPE) is not associated with an increased risk of death in cancer patients when compared to patients without pulmonary embolism (PE), according to research published in the October issue of the Journal of Thrombosis and Haemostasis.

Abstract
Full Text (subscription or payment may be required)

Neonatal Outcomes Unaffected by Transfused Blood Cell Age

MONDAY, Oct. 8 (HealthDay News) -- Premature, very-low-birth-weight infants requiring a blood transfusion do equally well if they receive fresh red blood cells (RBCs) or standard blood bank RBCs, according to a study published online Oct. 8 in the Journal of the American Medical Association to coincide with presentation at the annual meeting of AABB (formerly the American Association of Blood Banks), held from Oct. 6 to 9 in Boston.

Abstract
Full Text
More Information

Gene Variant Linked to Uterine Fibroid Risk

MONDAY, Oct. 8 (HealthDay News) -- A variant of a gene involved in fatty acid synthesis that is often overproduced in cancers is associated with a higher risk of developing uterine fibroids, according to research published in the Oct. 5 issue of the American Journal of Human Genetics.

Abstract
Full Text (subscription or payment may be required)

SNP in Gene Involved in Immunity Tied to Lung Cancer

MONDAY, Oct. 8 (HealthDay News) -- Genomic data suggest that a single nucleotide polymorphism (SNP) in the nuclear factor of kappa light polypeptide gene enhancer of B cells 1 (NFKB1) is associated with lung cancer, with the cytosine-thymine (CT)/TT genotype linked to reduced risk, according to a study published online Oct. 8 in Cancer.

Abstract
Full Text (subscription or payment may be required)

Potential New Colorectal Cancer Treatment Target Identified

FRIDAY, Oct. 5 (HealthDay News) -- The cell surface marker carcinoembryonic antigen-related cell adhesion molecule 6 (CD66c) is a novel marker for colorectal cancer stem cell isolation, which halts tumor growth when silenced, according to research published online Oct. 1 in Cancer.

Abstract
Full Text (subscription or payment may be required)

Anal Cancer Increase Linked to HIV Infection Only in Men

FRIDAY, Oct. 5 (HealthDay News) -- The rising incidence of anal cancer since 1980 in the United States is strongly impacted by HIV infection in men but not women, according to a study published online Oct. 5 in the Journal of the National Cancer Institute.

Abstract
Full Text (subscription or payment may be required)

Sexual Abuse May Affect Cervical Cancer Screening Rates

THURSDAY, Oct. 4 (HealthDay News) -- Women who have experienced sexual abuse as children or young adults are less likely to attend regular cervical cancer screenings, according to research published online in the October issue of the Journal of Family Planning & Reproductive Health Care.

Abstract
Full Text
Editorial

Predictors of Breast Cancer Locoregional Recurrence ID'd

THURSDAY, Oct. 4 (HealthDay News) -- In breast cancer patients treated with neoadjuvant chemotherapy (NC), independent predictors of locoregional recurrence (LRR) can be used to identify LRR risk, according to research published online Oct. 1 in the Journal of Clinical Oncology.

Abstract
Full Text (subscription or payment may be required)
Editorial

BMI and Lean Body Mass Decline After Allogeneic HSCT

THURSDAY, Oct. 4 (HealthDay News) -- In survivors of childhood hematologic malignancies who have received allogeneic hematopoietic stem cell transplantation (alloHSCT), body mass index (BMI) decreases significantly, mainly due to a reduction in lean, not fat, body mass, according to research published online Oct. 1 in the Journal of Clinical Oncology.

Abstract
Full Text (subscription or payment may be required)

Limiting the Problem of Missing Data Urged for Clinical Trials

WEDNESDAY, Oct. 3 (HealthDay News) -- Missing data compromise inferences from clinical trials, and due to the problematic nature of compensation with analysis methods, the importance of avoiding missing data in clinical trials is paramount, according to a special report published in the Oct. 4 issue of the New England Journal of Medicine.

Full Text (subscription or payment may be required)

Meta-Analysis Confirms Sunbed, Non-Melanoma Skin Cancer Link

WEDNESDAY, Oct. 3 (HealthDay News) -- Pooled results of multiple studies confirm that indoor tanning increases the risk of non-melanoma skin cancers, especially if tanning starts before 25 years of age, according to research published online Oct. 2 in BMJ.

Full Text
Editorial (subscription or payment may be required)

Digital Mammography Tops Screen-Film for Screening

TUESDAY, Oct. 2 (HealthDay News) -- Compared with screen-film mammography, digital mammography substantially improved the detection of ductal carcinoma in situ (DCIS) and invasive carcinoma, particularly when associated with microcalcifications, without an increase in clinically insignificant lesions, according to a study published online Oct. 2 in Radiology.

Abstract
Full Text (subscription or payment may be required)

New Database IDs Variants Linked to Colorectal Cancer

TUESDAY, Oct. 2 (HealthDay News) -- Sixteen variants at 13 loci have been identified as having a highly credible association with colorectal cancer, according to research published online Sept. 26 in the Journal of the National Cancer Institute.

Abstract
Full Text (subscription or payment may be required)

Observation Units Could Save $3.1 Billion Nationally Per Year

TUESDAY, Oct. 2 (HealthDay News) -- The addition of observation units to U.S. hospitals which do not currently have them in place could save $3.1 billion nationally per year in health care costs, according to a study published online Sept. 26 in Health Affairs.

Abstract
Full Text

Mortality Up With 80 Percent Oxygen in Abdominal Surgery

TUESDAY, Oct. 2 (HealthDay News) -- For patients undergoing abdominal surgery, use of 80 percent oxygen in the perioperative period is associated with an increased risk of long-term mortality, which is statistically significant for cancer patients but not for non-cancer patients, according to a study published in the October issue of Anesthesia & Analgesia.

Abstract
Full Text (subscription or payment may be required)

Patients Benefit From Access to Physician Notes

MONDAY, Oct. 1 (HealthDay News) -- Patients report clinically relevant benefits and minimal concerns, while doctors do not experience negative consequences, from allowing patient access to visit notes, according to a study published in the Oct. 1 issue of the Annals of Internal Medicine.

Abstract
Full Text
Editorial

Sexual Dysfunction Common With Aromatase Inhibitors

MONDAY, Oct. 1 (HealthDay News) -- Sexual dysfunction is common among postmenopausal women treated with aromatase inhibitors after breast cancer, according to a study published online Sept. 17 in Menopause.

Abstract
Full Text (subscription or payment may be required)

Higher Risk of Esophageal, Stomach Cancer With AIDS

MONDAY, Oct. 1 (HealthDay News) -- There is an increased risk of esophageal and stomach cancers among people with AIDS, according to a study published in the October issue of Gastroenterology.

Abstract
Full Text

Endorectal MRI Can Aid With Prostate Cancer Treatment Plan

MONDAY, Oct. 1 (HealthDay News) -- Endorectal magnetic resonance imaging (MRI) can help to predict upgrading on confirmatory biopsy and to identify which prostate cancer patients may benefit from active surveillance, according to a study published online Sept. 26 in The Journal of Urology.

Abstract
Full Text (subscription or payment may be required)
Editorial (subscription or payment may be required)

Imaging Method Can Assess Solid Tumor Aggressiveness

MONDAY, Oct. 1 (HealthDay News) -- The interstitial fluid pressure (IFP) of solid tumors, as measured using a new noninvasive, contrast-enhanced magnetic resonance imaging (MRI) method, may be useful as a novel potential biomarker for tumor aggressiveness and lymph node metastasis, according to a study published in the Oct. 1 issue of Cancer Research.

Abstract
Full Text

Specialties Hematology & Oncology

Copyright © 2012 ScoutNews, LLC. All rights reserved.


I Wish You Knew

Knowledge is Power

View More



Blogs and Web Chats

OncoLink Blogs give our readers a chance to react to and comment on key cancer news topics and provides a forum for OncoLink Experts and readers to share opinions and learn from each other.




OncoLink OncoPilot

Facing a new cancer diagnosis or changing the course of your current treatment? Let our cancer nurses help you through!

Learn More